» Articles » PMID: 3967417

The Closed Cryosurgical Treatment of Giant Cell Tumor

Overview
Publisher Wolters Kluwer
Specialty Orthopedics
Date 1985 Jan 1
PMID 3967417
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Twelve patients with giant cell tumor (GCT) treated by the closed method of cryotherapy along with curettage and bone grafting were reviewed retrospectively. Follow-up examinations ranged from two years and two months to 11 years. There was one osseous and one soft-tissue recurrence. There were no thermally related soft-tissue complications. Five patients suffered six postoperative pathologic fractures. Joint function was well preserved in ten of 12 patients, although five patients have varying degrees of joint pain or instability. Closed cryotherapy, curettage, and bone grafting are effective in the treatment of GCT. Special attention to surgical approach, controlled freezing, bone grafting technique, and a supervised rehabilitation program will minimize the incidence of postoperative pathologic fracture and maximize joint function.

Citing Articles

Postoperative Fracture Risk in Giant Cell Tumor: A Case Report and Review of Literature.

Kumar A, Keshav K, Singh S, Singh A Cureus. 2023; 15(9):e46192.

PMID: 37905245 PMC: 10613347. DOI: 10.7759/cureus.46192.


Effect of Local Adjuvants Following Curettage of Benign and Intermediate Tumours of Bone: A Systematic Review of the Literature.

Smolle M, Roessl V, Leithner A Cancers (Basel). 2023; 15(17).

PMID: 37686534 PMC: 10487159. DOI: 10.3390/cancers15174258.


'Triple clear': a systematic and comprehensive surgical process for Campanacci grades II and III giant cell tumors of the bone, with or without pathological fracture and slight joint invasion.

Wang Y, Shao P, Tian Q, Li H, Li J, Ren P World J Surg Oncol. 2023; 21(1):114.

PMID: 36978172 PMC: 10053671. DOI: 10.1186/s12957-023-02982-2.


Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis.

Sumari S, Mat Zin N, Wan Ismail W, Islam M Cancers (Basel). 2022; 14(14).

PMID: 35884399 PMC: 9318769. DOI: 10.3390/cancers14143338.


Risk factors of fracture following curettage for bone giant cell tumors of the extremities.

Tsukamoto S, Mavrogenis A, Akahane M, Honoki K, Kido A, Tanaka Y BMC Musculoskelet Disord. 2022; 23(1):477.

PMID: 35590280 PMC: 9118605. DOI: 10.1186/s12891-022-05447-x.